Thrombolysis by chemically modified coagulation factor Xa

E-ISSN： 1538-7836|14|9|1844-1854

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.14, Iss.9, 2016-09, pp. : 1844-1854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Snake Venom Prothrombin Activators Homologous to Blood Coagulation Factor Xa

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 3-6, 2002-03 ,pp. : 234-240

Karger

Access to resources Recommend Favorite

Indirect and direct anticoagulants predominantly inhibiting factor Xa

By Harenberg Job

Therapy, Vol. 5, Iss. 2, 2008-03 ,pp. : 177-192

Future Medicine

Access to resources Recommend Favorite

Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation

By Siddique Aurangzeb Lip Gregory YH Shantsila Eduard

Therapy, Vol. 6, Iss. 2, 2009-03 ,pp. : 187-189

Future Medicine

Access to resources Recommend Favorite

Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re‐appraisal

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S187-S194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 5, 2015-05 ,pp. : 838-846

John Wiley & Sons Inc

Access to resources Recommend Favorite